Literature DB >> 121298

Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei.

M Kazim, S K Puri, G P Dutta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 121298

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  7 in total

1.  A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.

Authors:  J M de Souza; U K Sheth; R M de Oliveira; A T Gomes; E Q Cavalcante
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.

Authors:  J M de Souza; U K Sheth; W H Wernsdorfer; P I Trigg; E B Doberstyn
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  Plasmodium falciparum: mefloquine resistance produced in vitro.

Authors:  C Lambros; J D Notsch
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

4.  A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.

Authors:  J M Ekue; O O Simooya; U K Sheth; W H Wernsdorfer; E K Njelesani
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 5.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

6.  Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.

Authors:  F Tin; N Hlaing; T Tun; S Win; R Lasserre
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.

Authors:  J Karbwang; D Bunnag; A M Breckenridge; D J Back
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.